Vident Investment Advisory, LLC Dynavax Technologies Corp Transaction History

Vident Investment Advisory, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$9.85 - $13.17 $114,023 - $152,455	11,576 New	11,576 $149,000
Q2 2019 Aug 12, 2019	SELL	$3.65 - $7.89 $537,166 - $1.16 Million	-147,169 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$7.08 - $12.09 $39,308 - $67,123	-5,552 Reduced 3.64%	147,169 $1.08 Million
Q4 2018 Feb 14, 2019	BUY	$8.14 - $13.28 $38,282 - $62,455	4,703 Added 3.18%	152,721 $1.4 Million
Q3 2018 Nov 14, 2018	SELL	$11.85 - $16.0 $124,330 - $167,872	-10,492 Reduced 6.62%	148,018 $1.84 Million
Q2 2018 Aug 14, 2018	BUY	$15.15 - $20.75 $1.02 Million - $1.39 Million	67,096 Added 73.4%	158,510 $2.42 Million
Q1 2018 May 14, 2018	BUY	$14.65 - $19.9 $368,828 - $501,002	25,176 Added 38.01%	91,414 $1.76 Million
Q4 2017 Feb 15, 2018	SELL	$17.3 - $24.08 $1.45 Million - $2.02 Million	-84,020 Reduced 55.92%	66,238 $1.24 Million
Q3 2017 Nov 14, 2017	BUY	$15.2 - $21.5 $2.28 Million - $3.23 Million	150,258	150,258 $3.23 Million

288

131M

507K

374K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.74B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.